These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 9199259
21. Assessment of non-reperfused and reperfused myocardial infarction using diffusible or deposited radiolabelled perfusion imaging agents. Riou LM, Broisat A, Lartizien C, Toufektsian MC, Maitrejean S, Janier M, Vanzetto G, Fagret D, Ghezzi C. Eur J Nucl Med Mol Imaging; 2007 Mar; 34(3):330-7. PubMed ID: 17004095 [Abstract] [Full Text] [Related]
22. Differential effects of cyclodextrins and derivatives on the biological behavior of the myocardial perfusion imaging agent 99mTcN-NOET. Riou L, Ghezzi C, Wouessidjewe D, Law H, Mathieu JP, Defaye J, Bontron R, Pasqualini R, Fagret D. Eur J Pharm Biopharm; 2005 Sep; 61(1-2):40-9. PubMed ID: 16000249 [Abstract] [Full Text] [Related]
28. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Okada RD, Glover D, Gaffney T, Williams S. Circulation; 1988 Feb; 77(2):491-8. PubMed ID: 3338137 [Abstract] [Full Text] [Related]
29. Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET: physicochemical identification of by-products and degradation species. Tisato F, Bolzati C, Refosco F, Porchia M, Seraglia R, Carta D, Pasqualini R. Nucl Med Biol; 2012 Apr; 39(3):335-46. PubMed ID: 22136886 [Abstract] [Full Text] [Related]
30. Comparison between Tc-99m N-NOET and Tl-201 in the assessment of patients with known or suspected coronary artery disease. Jeetley P, Sabharwal NK, Soman P, Kinsey C, Raval U, Bhonsle U, Lahiri A. J Nucl Cardiol; 2004 Apr; 11(6):664-72. PubMed ID: 15592189 [Abstract] [Full Text] [Related]
31. Tc-99m sestamibi defect magnitude predicts the amount of viable myocardium after coronary reperfusion despite the presence of severe residual stenosis. Takehana K, Ruiz M, Petruzella FD, Watson DD, Beller GA, Glover DK. J Nucl Cardiol; 2001 Apr; 8(1):40-8. PubMed ID: 11182708 [Abstract] [Full Text] [Related]
32. [Diagnosis of coronary artery disease with 99Tcm-N-NOET myocardial perfusion imaging]. Fan ZJ, Chen LB, Du YR, Long QM, Fang Q, Zhang SY, Yan XW, Shen ZJ, Jin XF, Shen JZ, Zhang DL, Zhu WL, Li F. Zhonghua Yi Xue Za Zhi; 2006 Jul 11; 86(26):1845-9. PubMed ID: 17054863 [Abstract] [Full Text] [Related]
37. Interaction of technetium-99m-N-NOET with blood elements: potential mechanism of myocardial redistribution. Johnson G, Nguyen KN, Pasqualini R, Okada RD. J Nucl Med; 1997 Jan 11; 38(1):138-43. PubMed ID: 8998168 [Abstract] [Full Text] [Related]
38. Subcellular distribution of technetium-99m-N-NOEt in rat myocardium. Uccelli L, Giganti M, Duatti A, Bolzati C, Pasqualini R, Cittanti C, Colamussi P, Piffanelli A. J Nucl Med; 1995 Nov 11; 36(11):2075-9. PubMed ID: 7472602 [Abstract] [Full Text] [Related]
39. Myocardial accumulation and clearance of technetium 99m teboroxime at 100%, 75%, 50% and zero coronary blood flow in dogs. Pieri P, Yasuda T, Fischman AJ, Ahmad M, Moore R, Yaoita H, Strauss HW. Eur J Nucl Med; 1991 Nov 11; 18(9):725-31. PubMed ID: 1936048 [Abstract] [Full Text] [Related]
40. Influence of calcium channel inhibitors on the myocardial uptake and retention of technetium 99m N-NOET, a new myocardial perfusion imaging agent: a study on isolated perfused rat hearts. Riou L, Ghezzi C, Pasqualini R, Fagret D. J Nucl Cardiol; 2000 Nov 11; 7(4):365-72. PubMed ID: 10958279 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]